Clinical Trials Browser

Phase 1/2 × Not yet recruiting × Carcinoma, Merkel Cell × Clear all

NCT07472322 2026-05-29

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

Phase 1/2 Not yet recruiting

Carcinoma, Merkel Cell